4.5 Article

Axin cancer mutants form nanoaggregates to rewire the Wnt signaling network

Journal

NATURE STRUCTURAL & MOLECULAR BIOLOGY
Volume 23, Issue 4, Pages 324-332

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nsmb.3191

Keywords

-

Funding

  1. European Research Council ((ERC)) [242958, 294523]
  2. Utrecht University
  3. Boehringer Ingelheim Fonds
  4. European Union [ITN 608180, ITN-IDP 317371, 25651, 261863]
  5. Netherlands Organization for Scientific Research ((NWO))
  6. Internationale Stichting Alzheimer Onderzoek ((ISAO))
  7. Medical Research Council of Great Britain [U117584268]
  8. European Molecular Biology Organization ((EMBO)) [ALTF 983-2009]
  9. Uehara Foundation
  10. Kanae Foundation
  11. Austrian Academy of Sciences (APART)
  12. Bavarian Ministry of Sciences, Research and the Arts in the framework of the Bavarian Molecular Biosystems Research Network
  13. German Research Foundation (Emmy Noether program) [MA 5703/1-1]
  14. NWO embedded roadmap program Proteins@Work [184.032.201]
  15. PRIME-XS - European Union FP7 [262067]
  16. European Research Council (ERC) [294523] Funding Source: European Research Council (ERC)
  17. The Francis Crick Institute [10205, 10204] Funding Source: researchfish

Ask authors/readers for more resources

Signaling cascades depend on scaffold proteins that regulate the assembly of multiprotein complexes. Missense mutations in scaffold proteins are frequent in human cancer, but their relevance and mode of action are poorly understood. Here we show that cancer point mutations in the scaffold protein Axin derail Wnt signaling and promote tumor growth in vivo through a gain-of-function mechanism. The effect is conserved for both the human and Drosophila proteins. Mutated Axin forms nonamyloid nanometer-scale aggregates decorated with disordered tentacles, which 'rewire' the Axin interactome. Importantly, the tumor-suppressor activity of both the human and Drosophila Axin cancer mutants is rescued by preventing aggregation of a single nonconserved segment. Our findings establish a new paradigm for misregulation of signaling in cancer and show that targeting aggregation-prone stretches in mutated scaffolds holds attractive potential for cancer treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available